Optical Coherence Tomography, Optical Coherence Tomography Angiography
Conditions
Keywords
Normative database, Healthy subjects, Optical coherence tomography, Optical coherence tomography angiography, Heidelberg, Vascular density
Brief summary
Optical coherence tomography angiography (OCT-A) is a determinant progress to study retinal and choroidal vasculature without using a dye injection. OCT-A yields interesting results in different pathologies such as diabetes mellitus, age-related macular degeneration, hypertension blood pressure, particularly by affecting vascular density. Normative database are necessary to compare OCT-A parameters between patients and controls. However, OCT-A devices from different manufactures may give different values for the same subject. It seems to be obvious that each OCT-A device should have its own normative database. In the literature, OCT-A normative databases are developing using different types of devices, but none is available for Heidelberg OCT-A in Caucasians. The purpose of this project is to create a normative database of retinal microvascularisation using Spectralis Heidelberg optical coherence tomography angiography (OCT-A) ® in normal controls.
Interventions
Optical coherence tomography angiography
ophthalmological exam
Sponsors
Study design
Eligibility
Inclusion criteria
* Voluntary adult subjects or legal representative consenting for minor or subjects under protection * Intra ocular pression ≤ 21mmHg * Spherical refraction comprised between - 6 D and +6 D and/or axial length between 21 and 26mm * Patient affiliated to social security system
Exclusion criteria
* Ocular diseases: glaucoma, retinal diseases as diabetic retinopathy, age-related macular degeneration, amblyopia, optic neuropathy * Diabetes mellitus * Uncontrolled hypertension blood pressure (\> 140/90) * Recent ocular surgery (\< 6 months) * Any ophthalmological conditions interfering with a good ocular examination or OCT quality (cataract, corneal opacity …) * OCT-A sufficient quality ≥ 25 (0 = bad quality /40 = excellent quality * Not consenting patient * Pathological situation or handicap avoiding good installation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| vascular density of superficial capillary plexus measurement | one day | vascular density of superficial capillary plexus measurement |
| vascular density of deep capillary plexus measurement | one day | vascular density of deep capillary plexus measurement |
| choriocapillaris density in macular zone | one day | choriocapillaris density in macular zone |
| choriocapillaris density in peripapillary zone | one day | choriocapillaris density in peripapillary zone |
Countries
France